Synedica Laboratories

Metabolic & Body Composition

Tesamorelin

GHRH analogue stabilised with trans-3-hexenoic acid. Studied for GHRH receptor binding, IGF-1 output and visceral adipose models.

Also known asEgrifta · TH9507

Identity

Residue chain

One bead per amino acid residue, N-terminus to C-terminus. Long chains are shown truncated.

Molecular weight
5136.0 Da
Amino acid residues
44
Half-life
~30 min
CAS number
218949-48-9

Monograph

Specifications

Research area
Metabolic & Body Composition
Half-life
~30 min
Molecular weight
5136.0 Da
Amino acid residues
44
CAS number
218949-48-9
Formula
C₂₂₁H₃₆₆N₇₂O₆₇S
Sequence
trans-3-hexenoyl-GHRH(1-44)NH₂ (Tyr-Ala-Asp-Ala-Ile-Phe...44 aa)
Designation
trans-3-hexenoyl-Tyr¹-hGRF(1-44)NH₂

Pharmacokinetics

Half-life
~30 min
T-max
~15 min
C-max
2.9–3.5 ng/mL
Bioavailability
~4% SC (peptide)
Route
Subcutaneous (research use)

Receptor targets

  • GHRH receptorPituitary agonist
  • Anterior pituitary somatotrophsEndogenous GH release

Signalling cascade

  1. 1GHRH-R binding
  2. 2Gαs activation
  3. 3cAMP ↑
  4. 4GH secretion
  5. 5Hepatic IGF-1 production
  6. 6Lipolysis (visceral fat)
Mechanism of action
Synthetic analogue of endogenous GHRH(1-44) stabilized with trans-3-hexenoic acid at the N-terminus. Binds pituitary GHRH receptors to stimulate endogenous GH secretion and downstream IGF-1 production while preserving natural feedback regulation via somatostatin.
Storage and handling
Refrigerate at 2–8 °C after reconstitution. Do not freeze.

Research focus

  • 01Visceral adipose tissue metabolism and lipolysis
  • 02IGF-1 axis activation and growth factor cascade
  • 03Endocrine feedback regulation via somatostatin
  • 04Lipodystrophy and metabolic dysfunction models
  • 05Sustained GHRH receptor binding pharmacokinetics

Overview

Tesamorelin is a GHRH analogue stabilised with trans-3-hexenoic acid at the N-terminus, which slows DPP-IV cleavage. It binds pituitary GHRH receptors to raise endogenous GH and downstream IGF-1, and is used in visceral adipose and endocrine feedback models.